Duncan Emerton

Duncan Emerton has experience across a broad range of pharma disciplines including R&D, sales, marketing, medical affairs, competitive intelligence, management consulting and business analysis. Duncan currently heads up FirstWord’s syndicated reports business, where he’s responsible for delivering future-focused research and analysis across a wide range of topics. “My current passion is biosimilars,” says Duncan. “I’m a regular presenter and chair at biosimilar-focused conferences, and I’ve contributed several articles and book chapters on the subject.” In his spare time he plays golf and runs The Biosimilarz Blog.